Effervescent tablet containing a salicylic acid-forming agent

Abstract From the Canadian patent

It is known to produce effervescent tablets incorporating salicyl acid analgetics gained synthetically and, if required, vitamin adjuvants. In order to avoid the disadvantages of synthetically manufactured salicyl acid in such effervescent tablets, namely the irritation of the gastric mucosas and the inhibition of thrombocyte aggregation, and simultaneously to bring about new fields of use for effervescent tablets an effervescent, tablet is suggested which has as an analgesic agent, forming salicylic acid a water-soluble plant extract of, the salicis extract type (willow bark extract) with a high active substance content. Thus, a galenically appropriate administration form of these …